X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Aventis Pharma with Elder Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANOFI INDIA vs ELDER PHARMA - Comparison Results

SANOFI INDIA    Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SANOFI INDIA ELDER PHARMA SANOFI INDIA/
ELDER PHARMA
 
P/E (TTM) x 36.5 -0.2 - View Chart
P/BV x 6.9 0.1 6,819.2% View Chart
Dividend Yield % 0.6 0.0 -  

Financials

 SANOFI INDIA   ELDER PHARMA
EQUITY SHARE DATA
    SANOFI INDIA
Dec-17
ELDER PHARMA
Jun-14
SANOFI INDIA/
ELDER PHARMA
5-Yr Chart
Click to enlarge
High Rs4,945380 1,301.3%   
Low Rs3,901188 2,075.0%   
Sales per share (Unadj.) Rs1,081.8491.2 220.2%  
Earnings per share (Unadj.) Rs141.6-3.2 -4,449.2%  
Cash flow per share (Unadj.) Rs185.914.4 1,290.4%  
Dividends per share (Unadj.) Rs33.000-  
Dividend yield (eoy) %0.70-  
Book value per share (Unadj.) Rs868.8376.5 230.7%  
Shares outstanding (eoy) m23.0320.54 112.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.10.6 707.1%   
Avg P/E ratio x31.2-89.3 -35.0%  
P/CF ratio (eoy) x23.819.7 120.7%  
Price / Book Value ratio x5.10.8 674.9%  
Dividend payout %23.30-   
Avg Mkt Cap Rs m101,8625,833 1,746.2%   
No. of employees `0003.2NA-   
Total wages/salary Rs m3,6852,179 169.1%   
Avg. sales/employee Rs Th7,691.9NM-  
Avg. wages/employee Rs Th1,137.7NM-  
Avg. net profit/employee Rs Th1,006.5NM-  
INCOME DATA
Net Sales Rs m24,91410,089 246.9%  
Other income Rs m807257 314.5%   
Total revenues Rs m25,72110,346 248.6%   
Gross profit Rs m5,372-792 -678.4%  
Depreciation Rs m1,022361 282.9%   
Interest Rs m112,756 0.4%   
Profit before tax Rs m5,146-3,653 -140.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m03,713 0.0%   
Tax Rs m1,886125 1,507.0%   
Profit after tax Rs m3,260-65 -4,988.5%  
Gross profit margin %21.6-7.8 -274.7%  
Effective tax rate %36.6-3.4 -1,069.7%   
Net profit margin %13.1-0.6 -2,020.1%  
BALANCE SHEET DATA
Current assets Rs m14,4329,240 156.2%   
Current liabilities Rs m6,0109,998 60.1%   
Net working cap to sales %33.8-7.5 -450.1%  
Current ratio x2.40.9 259.8%  
Inventory Days Days6146 131.5%  
Debtors Days Days2860 47.5%  
Net fixed assets Rs m7,99110,124 78.9%   
Share capital Rs m230206 112.0%   
"Free" reserves Rs m19,7785,582 354.3%   
Net worth Rs m20,0087,734 258.7%   
Long term debt Rs m04,889 0.0%   
Total assets Rs m27,77022,882 121.4%  
Interest coverage x468.8-0.3 -144,122.6%   
Debt to equity ratio x00.6 0.0%  
Sales to assets ratio x0.90.4 203.5%   
Return on assets %11.811.8 100.2%  
Return on equity %16.3-0.8 -1,928.1%  
Return on capital %25.822.3 115.5%  
Exports to sales %03.0 0.0%   
Imports to sales %00.4 0.0%   
Exports (fob) Rs mNA307 0.0%   
Imports (cif) Rs mNA43 0.0%   
Fx inflow Rs m6,306307 2,056.8%   
Fx outflow Rs m5,257125 4,195.5%   
Net fx Rs m1,049181 578.6%   
CASH FLOW
From Operations Rs m4,35111,754 37.0%  
From Investments Rs m-787-561 140.4%  
From Financial Activity Rs m-1,884-6,762 27.9%  
Net Cashflow Rs m1,6804,432 37.9%  

Share Holding

Indian Promoters % 0.0 39.6 -  
Foreign collaborators % 60.4 0.0 -  
Indian inst/Mut Fund % 14.4 7.5 192.0%  
FIIs % 14.6 16.8 86.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 10.5 36.1 29.1%  
Shareholders   15,184 16,479 92.1%  
Pledged promoter(s) holding % 0.0 77.6 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SANOFI INDIA With:   PLETHICO PHARMA  BIOCON LTD  FULFORD INDIA  ALKEM LABORATORIES  AJANTA PHARMA  

Compare SANOFI INDIA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 404 Points Higher; Metal and Oil & Gas Stocks Witness Buying(Closing)

Indian share markets continued their momentum during closing hours and ended the day on a strong note. Gains were largely seen in the metal sector and oil & gas sector.

Related Views on News

SANOFI INDIA Announces Quarterly Results (2QFY19); Net Profit Up 2.5% (Quarterly Result Update)

Nov 6, 2018 | Updated on Nov 6, 2018

For the quarter ended September 2018, SANOFI INDIA has posted a net profit of Rs 1 bn (up 2.5% YoY). Sales on the other hand came in at Rs 7 bn (up 11.4% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA Announces Quarterly Results (1QFY19); Net Profit Up 35.1% (Quarterly Result Update)

Jul 27, 2018 | Updated on Jul 27, 2018

For the quarter ended June 2018, SANOFI INDIA has posted a net profit of Rs 996 m (up 35.1% YoY). Sales on the other hand came in at Rs 7 bn (up 13.8% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA Announces Quarterly Results (4QFY18); Net Profit Up 37.5% (Quarterly Result Update)

Jul 20, 2018 | Updated on Jul 20, 2018

For the quarter ended March 2018, SANOFI INDIA has posted a net profit of Rs 825 m (up 37.5% YoY). Sales on the other hand came in at Rs 6 bn (up 11.7% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

More Views on News

Most Popular

The RCom Bankruptcy: 5 Lessons for Smallcap Investors(Profit Hunter)

Feb 7, 2019

Managements of companies can create or ruin their fortunes. Why is management quality such an important factor in valuing businesses? Read on to find out...

The One Real Estate Stock to Buy Now(The 5 Minute Wrapup)

Feb 13, 2019

The real estate sector is ready to make a comeback. This is the stock to consider buying.

How We Pick the Most Profitable Stocks from the Portfolios of Super Investors(The 5 Minute Wrapup)

Feb 8, 2019

This is the trick to following super investors and not losing money.

Don't Be Afraid of the Market; Buy Stocks Like This One(The 5 Minute Wrapup)

Feb 14, 2019

During this tough period in the market, a contrarian approach holds huge potential upside for this Smart Money Secrets stock.

Small Caps Under Seige: Could This Be A Once-in-a-Decade Wealth Creating Opportunity?(Profit Hunter)

Feb 14, 2019

Don't let the dark clouds hovering over small caps scare you into hiding; it will rain gold as sentiments recover. Indeed, there is a blood bath. And if you are a first time investor, the correction is deep enough to scare you out of markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

SANOFI INDIA SHARE PRICE


Feb 20, 2019 (Close)

TRACK SANOFI INDIA

  • Track your investment in SANOFI INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SANOFI INDIA 5-YR ANALYSIS

COMPARE SANOFI INDIA WITH

MARKET STATS